Sean Cunningham, GTCR
Managing Director, GTCR,
Sean joined GTCR in 2001 and is currently a Managing Director of the firm. He was previously a Consultant with The Boston Consulting Group. Sean holds an MBA from the Wharton School at the University of Pennsylvania as well as AB and BE degrees in engineering sciences from Dartmouth College.
Sean currently is a Director of Albany Molecular Research, Antylia Scientific, Ceba-Tech, Cedar Gate Technologies, Corza Health, Maravai LifeSciences, Regatta, Riverchase Dermatology, Sotera and Transaction Data Systems. He was instrumental in GTCR’s past investments in Cord Blood Registry, Devicor Medical Products, Graceway Pharmaceuticals and Ovation Pharmaceuticals.
Videos
-
Life Sciences Gets a COVID Booster Shot
Three veterans of the life sciences private equity and M&A market share intel about dramatic changes in the industry.
March 1, 2021More
Reports
-
Life Sciences Gets a COVID Booster Shot
Three veterans of the life sciences private equity and M&A market share intel about dramatic changes in the industry.
March 29, 2021More
Privcap Email Updates
Subscribe to receive email notifications whenever new talks are published.